Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes by Maria Teresa Petrucci, Sara Bringhen, Cristina Entrala Cerezo, João Mendes, Patrizio Armeni

Get full text

30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis by Enrique M. Ocio, Aurore Perrot, Philippe Moreau, Maria‐Victoria Mateos, Sara Bringhen, Joaquín Martínez‐López, Lionel Karlin, Song‐Yau Wang, Corina Oprea, Yi Li, Ercem Kodas, Jesus San‐Miguel

Get full text

Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial by Sara Bringhen, Lorenzo Cani, Nicola Giuliani, Silvia Mangiacavalli, Giulia Benevolo, Elisabetta Antonioli, Renato Zambello, Roberto Ria, Iolanda Donatella Vincelli, Sonia Ronconi, Sonia More, Antonietta Pia Falcone, Alessandro Allegra, Mattia D'Agostino, Andrea Evangelista, Andrea Capra, Elisa Sciorsci, Paola Curci, Patrizia Tosi, Anna Marina Liberati, Anna Maria Cafro, Angelo Belotti, Francesca Patriarca, Donato Mannina, Katia Mancuso, Francesco Cattel, Giovannino Ciccone, Benedetto Bruno, Mario Boccadoro, Alessandra Larocca

Get full text

Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes by Alberto Mella, Alberto Mella, Roberta Clari, Roberta Clari, Valeria Deiana, Valeria Deiana, Roberta Giraudi, Roberta Giraudi, Gloria Giovinazzo, Gloria Giovinazzo, Ester Gallo, Ester Gallo, Caterina Dolla, Caterina Dolla, Antonio Lavacca, Antonio Lavacca, Ana Maria Manzione, Ana Maria Manzione, Fabrizio Fop, Fabrizio Fop, Anna Allesina, Anna Allesina, Federica Cavallo, Sara Bringhen, Dario Ferrero, Roberto Mina, Corrado Tarella, Corrado Tarella, Benedetto Bruno, Filippo Mariano, Filippo Mariano, Luigi Biancone, Luigi Biancone

Get full text